Facebook
Twitter
LinkedIn
ForwardHot Topics in Public Health — A Symposium Series 2024-2025
Overview
The "Hot Topics in Public Health" symposium series is a forum to provide up-to-date information on breaking issues in public health. The series adopts various formats for education, including panel discussions, scholarly presentations, and audience-based question and answer. Hot topics are selected by a steering committee of public health professionals, population health researchers, and clinicians at the University of Wisconsin School of Medicine and Public Health.
Elements of Competence
American Board of Medical Specialties:
- Professionalism
- Interprofessional and communication skills
- Patient-centered care
- Population Health
Interprofessional communication
- Values and ethics
- Teams and teamwork
DEI Competencies
- Address health disparities
- Engage in Self-reflection
Intended Audience
The target audience for this accredited continuing education includes physicians and public health professionals.
Learning Objectives
See individual sessions for specific learning outcomes.
See individual sessions for the agenda.
Planners
Jonathan Temte, MD, PhD, MS
Maureen Durkin, PhD, DrPH
Sheri Johnson, PhD
Parvathy Pillai, PhD, MPH
Patrick Remington, MD, MPH
Elizabeth Salisbury-Afshar, MD, MPH
Ajay Sethi, PhD, MHS
Policy on Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence the content of this accredited continuing education (CE). In addition, speakers, presenters, and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation. For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
Name | Role | Financial Relationship Disclosures | Discussion of Unlabeled/Unapproved uses of drugs/devices in presentation? |
| Jonathan L. Temte, MD, PhD | Course Director | Quidel Corporation (Grant / Contract) | Yes |
| Maureen Durkin, PhD, DrPH | Planner | No relevant relationships with ineligible companies to disclose | No |
| Sheri Johnson, PhD | Planner | No relevant relationships with ineligible companies to disclose | No |
| Parvathy Pillai, PhD, MPH | Planner | No relevant relationships with ineligible companies to disclose | Yes |
| Patrick Remington, MD, MPH | Planner | No relevant relationships with ineligible companies to disclose | No |
| Elizabeth Salisbury-Afshar, MD, MPH | Planner | No relevant relationships with ineligible companies to disclose | No |
| Ajay Sethi, PhD, MHS | Planner | No relevant relationships with ineligible companies to disclose | No |
| Shezad Baloch | Accreditation Specialist | No relevant relationships with ineligible companies to disclose | No |
*Ineligible companies are those whose primary business is producing, marketing, selling, re‐selling, or distributing healthcare products used by or on, patients.
The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.